Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
   Serine/threonine kinases
     AGC group
     CAMK group
     CMGC group
       CDK1 [HSA:983] [KO:K02087]
       CDK2 [HSA:1017] [KO:K02206]
       CDK4/6 [HSA:1019 1021] [KO:K02089 K02091]
       CDK4 [HSA:1019] [KO:K02089]
       CDK6 [HSA:1021] [KO:K02091]
       CDK7 [HSA:1022] [KO:K02202]
       CDK9 [HSA:1025] [KO:K02211]
       CDK5 [HSA:1020] [KO:K02090]
       ERK [HSA:5594 5595] [KO:K04371]
       JNK [HSA:5599 5601 5602] [KO:K04440]
       P38 [HSA:1432 5600 5603 6300] [KO:K04441]
         D03736  Doramapimod (USAN/INN)
         D09602  Dilmapimod (USAN/INN)
         D09603  Dilmapimod tosylate (USAN)
         D09639  Losmapimod (USAN/INN)
         D10658  Ralimetinib (USAN/INN)
         D10659  Ralimetinib mesylate (USAN)
         D10959  Neflamapimod (USAN)
 
 
 
 
 
 
 
       P38alpha (MAPK14) [HSA:1432] [KO:K04441]
       CLK2 [HSA:1196] [KO:K08823]
       DYRK1A [HSA:1859] [KO:K08825]
     STE group
     TKL group
     Other
   Receptor serine/threonine kinases (RSTK)
   Receptor tyrosine kinases (RTK)
   Non-receptor tyrosine kinases
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 19, 2019

» Japanese version